Review
2026
[Integration of novel anti-tumor agents and allogeneic hematopoietic stem cell transplantation].
Y. Najima
· [Rinsho ketsueki] The Japane... · 0 citations
We have 3 of 275 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Review
2026
[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].
Y. Najima
· [Rinsho ketsueki] The Japane... · 0 citations
Case report
Open access
Aug 2026
Case Report: Immune-directed post-transplant maintenance with low-dose gemtuzumab ozogamicin and stepwise donor lymphocyte infusion in acute myeloid leukemia with t(1;3)(p36.3;q21)
This case suggests that sequential low-dose GO followed by stepwise DLI may support durable remission when used as a post-transplant maintenance strategy in chemo-refractory AML with adverse cytogenetics, such as t(1;3)(p36.3;q21).
Fumihiko Ouchi, Y. Najima, K. Haraguchi et al.
· Frontiers in Immunology · 0 citations